Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum Sample Collection for Fluzone Quadrivalent and Fluzone High-Dose Quadrivalent (2021-2022)
NCT05050318Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2021
- Primary completion
- Nov 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated), Efluelda in influenza, sponsored by Sanofi. Started Sep 2021; status: completed.
02
Drugs
Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated)Efluelda
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05050318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05050318.